ArticleMolecular pharmaceutics2018

Inhibition of Human CYP3A4 by Rationally Designed Ritonavir-Like Compounds: Impact and Interplay of the Side Group Functionalities.

Eric R Samuels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.